Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
8.99
-0.10 (-1.15%)
May 14, 2025, 10:30 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Log In
Immune-based Therapies Growth
-90.00%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
Log In
United States Growth
-90.00%
Log In